| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.26 | 0.06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |